Results 201 to 210 of about 58,258 (229)
Some of the next articles are maybe not open access.

The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism

Thrombosis Research, 2019
The Ottawa score was previously developed to predict recurrent venous thromboembolism (VTE) in cancer patients with VTE. The performance of this score in patients with incidental VTE is currently unclear.To evaluate the performance of the Ottawa risk score in cancer patients with incidental pulmonary embolism included in an international, prospective ...
Nick VAN ES   +2 more
exaly   +5 more sources

Validation of the clinical prediction rule for recurrent venous thromboembolism in cancer patients: the Ottawa score

Supportive Care in Cancer, 2013
Recently, a clinical prediction rule for recurrent venous thromboembolism (VTE) in cancer patients, named Ottawa score, was derived to individualize treatments with different intensities. It is composed of four variables including sex, primary tumor site, tumor stage, and prior history of VTE.
Shin Ahn, Yoon-Seon Lee, Jaelyun Lee
exaly   +3 more sources

Continued Validation of the O-SCORE (Ottawa Surgical Competency Operating Room Evaluation): Use in the Simulated Environment

Teaching and Learning in Medicine, 2016
CONSTRUCT: The Ottawa Surgical Competency Operating Room Evaluation (O-SCORE) is a 9-item surgical evaluation tool designed to assess technical competence in surgical trainees using behavioral anchors.The initial development of the O-SCORE produced evidence for valid results.
Timothy Wood   +2 more
exaly   +3 more sources

The Modified Ottawa Score and Clinical Events in Hospitalized Patients with Cancer-Associated Thrombosis from the Swiss VTE Registry

Seminars in Thrombosis and Hemostasis, 2017
AbstractThe modified Ottawa score (MOS) predicted venous thromboembolism (VTE) recurrence in a cohort of patients with cancer-associated thrombosis mainly managed on an outpatient basis. We aimed to assess the prognostic value of the MOS in hospitalized patients with cancer-associated thrombosis.
Jürg Hans Beer, Wolfgang Korte
exaly   +6 more sources

Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry

Thrombosis and Haemostasis, 2017
SummaryTreatment of patients with cancer-associated venous thromboembolism (VTE) remains a major challenge. The modified Ottawa score is a clinical prediction rule evaluating the risk of VTE recurrences during the first six months of anticoagulant treatment in patients with cancer-related VTE.
Alfonso Tafur   +2 more
exaly   +5 more sources

Utility of the modified Ottawa score for identification of more preferable candidates of extended anticoagulation therapy in cancer-associated isolated distal deep vein thrombosis: insight from the ONCO DVT Study

Journal of Thrombosis and Haemostasis
The ONCO DVT study (Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis) revealed superiority of 12-month relative to 3-month edoxaban treatment for the thrombotic risk in cancer-associated isolated distal deep vein thrombosis.
Ayumi Shikama   +2 more
exaly   +3 more sources

Comparison of Emergency Heart Failure Mortality Risk Grade and Ottawa Heart Failure Risk Score Scores in Predicting Mortality in Patients Presenting to the Emergency Department with Heart Failure

Journal of Emergency Medicine
Patients discharged from the emergency department (ED) with acute decompensated heart failure (ADHF) face high mortality risks, which may render disposition decisions challenging. While clinical judgment is prominent, objective risk stratification tools such as the Emergency Heart Failure Mortality Risk Grade (EHMRG) and the Ottawa Heart Failure Risk ...
Huseyin Cahit Halhalli, Asim Enes Özbek
exaly   +3 more sources

Home - About - Disclaimer - Privacy